Citizen engagement through tangible data representation

We begin with the premise that data literacy is a fundamental facet of citizen education in this information age, and that an engaged citizenry in a democracy not only requires access to data, but also the capacity to manipulate and examine the data from multiple perspectives. The visualization of data elucidates trends and patterns in the phenomena that the data represents, and opens accessibility to understanding complicated human and natural processes represented by data sets. Research indicates that interacting with a visualization amplifies cognition and analysis. A single visualization may show only one facet of the data. To examine the data from multiple perspectives, engaged citizens need to be able to construct their own visualizations from a data set. Many tools for data visualization have responded to this need, allowing non-data experts to manipulate and gain insights into their data, but most of these tools are restricted to the computer screen, keyboard, and mouse. Cognition and analysis may be strengthened even more through embodied interaction with data. We present here the rationale for the design of a tool that allows users to probe a data set, through interactions with graspable (tangible) three-dimensional objects, rather than through a keyboard and mouse interaction. We argue that the use of tangibles facilitates understanding abstract concepts, and facilitates many concrete learning scenarios. Another advantage of using tangibles over screen-based tools is that they foster collaboration, which can promote a productive working and learning environment. We speculate that collaborative data exploration can be a productive educational activity for citizens in their communities and in the classroom, and we suggest our tool as a means to do this

Fostering Insight and Collaboration in Long-Term Healthcare through Collection and Visualization of Qualitative Healthcare Data

The Care and Condition Monitor (CCM) is a tablet-based, networked visual analytics tool for collecting, structuring and analyzing informal and qualitative healthcare data. Building off research into application usability and best practices for communicating complex information, CCM illustrates how visual analytics tools coupled with social communication within teams of caregivers enables capturing of longitudinal informal data that would otherwise go unrecorded. This expanded scope of information can support medical decision making by making it possible to analyze informal and qualitative health care data,creating a multi-dimensional holistic picture of a person‟s health care and condition over time

The Sophi HUD: A novel visual analytics tool for news media

The Sophi Heads-up Display (HUD) is an analytics tool developed for editors at Canada's The Globe and Mail newspaper that overlays relevant data about articles' performances onto The Globe and Mail website. We describe the motivation for our research, our design process (which includes initial needs assessment through semi-structured interviews with editors, and job shadowing), and the validation of features with users. We then discuss the ongoing iterations of the Sophi HUD and how its design was informed through collaboration with The Globe and Mail employees

Analyzing student travel patterns with augmented data visualizations

Visualization and visual analytics tools can provide critical support for experts and stakeholders to understand transportation flows and related human activities. Correlating and representing quantitative data with data from human actors can provide explanations for patterns and anomalies. We conducted research to compare and contrast the capabilities of several tools available for visualization and decision support as a part of an integrated urban informatics and visualization research project that develops tools for transportation planning and decision making. For this research we used the data collected by the StudentMoveTO (Toronto) survey which was conducted in the fall of 2015 by Toronto's four universities with the goal of collecting detailed data to understand travel behaviour and its effect on the daily routines of the students. This paper discusses the usefulness of new software which can allow designers to build meaningful narratives integrating 3D representations to assist in Geo-spatial analysis of the data

Uncovering inclusivity gaps in design pedagogy through the digital design marginalization framework

Designers play a key role in the design of inclusive and socially conscious interfaces. Thus, it is imperative for designers to be thoughtful of the ethical and social implications of design. However, gaps in the foundational training that designers receive (e.g., as university students) can negatively impact their ability to consider the social implications of their design practice. This can result in consequences such as digital marginalization, which, as defined by the Digital Design Marginalization (DDM) framework, is the “pushing away”, whether intentional or not, of a defined group of users from a digital or online service or system, where the exclusion has additional, indirect, and long-lasting social consequences on that particular user group. Designers can contribute, even unintentionally, to digital marginalization through their design practices and the design choices they make. We argue that our role as educators includes ensuring not only that our design pedagogy is inclusive, but that the designers we train now are prepared to conduct their future design practice in a manner that is inclusive to all users. As such, we propose to use the Digital Design Marginalization as a lens to guide a reflection-based approach to identify gaps in our pedagogy that may lead to designers becoming ill-equipped to identify how their designs may lead to digital marginalization. Through seven case studies from our own teaching practice, we demonstrate the use of the DDM framework to guide marginalization-focused introspective reflections of curricula. These reflections through the DDM lens revealed gaps in our pedagogy with respect to providing future designers with training that enables them to consider the broader societal and individual implications of the design choices they will make in future practice. Based on our experience using the DDM framework, we then discuss in greater depth how reflection of social consequences of design pedagogy can be operationalized within institutions to reduce educational gaps that may be associated with design-mediated digital marginalization. Finally, we comment on avenues for further development of pedagogical reflection using DDM

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

BACKGROUND: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. METHODS: This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. FINDINGS: Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. INTERPRETATION: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. FUNDING: UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. Findings Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. Interpretation ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials

Datos de materialización: Notas sobre colaboración e interfaces tangibles con extractos y adiciones

The visualization of data elucidates trends and patterns in the phenomena that the data represents, and opens accessibility to understanding complicated human and natural processes represented by data sets. Research indicates that interacting with a visualization amplfies cognition and analysis. A single visualization may show only one facet of the data. To examine the data from multiple perspectives, engaged citizens need to be able to construct their own visualizations from a data set. Many tools for data visualization have responded to this need, allowing non-data experts to manipulate and gain insights into their data, but most of these tools are restricted to the computer screen, keyboard, and mouse. Cognition and analysis may be strengthened even more through embodied interaction with data, whether through data sculpture or haptic and tangible interfaces. We present here the rationale for the design of a tool that allows users to probe a data set, through interactions with graspable (tangible) three-dimensional objects, rather than through a keyboard and mouse interaction. We argue that the use of tangibles facilitates understanding abstract concepts, and facilitates many concrete learning scenarios. Another advantage of using tangibles over screen-based tools is that they foster collaboration, which can promote a productive working and learning environment

Bibliographic Displays in Web Catalogs: Does Conformity to Design Guidelines Correlate with User Performance?

The present study investigated whether there is a correlation between user performance and compliance with screen-design guidelines found in the literature. Rather than test individual guidelines and their interactions, the authors took a more holistic approach and tested a compilation of guidelines. Nine bibliographic display formats were scored using a checklist of eighty-six guidelines. Twenty-seven participants completed ninety search tasks using the displays in a simulated Web environment. None of the correlations indicated that user performance was statistically significantly faster with greater conformity to guidelines. In some cases, user performance was actually significantly slower with greater conformity to guidelines. In a supplementary study, a different set of forty-three guidelines and the user performance data from the main study were used. Again, none of the correlations indicated that user performance was statistically significantly faster with greater conformity to guidelines